Cabometyx (cabozantinib)

pCPA File Number: 21238
Negotiation Status:
Active Negotiation
Indication(s):
hepatocellular carcinoma
Sponsor/Manufacturer:
Ipsen Biopharmaceuticals
CADTH Project Number:
pCODR 10186
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable